ID   TPA_HUMAN               Reviewed;         562 AA.
AC   P00750; A8K022; B2R8E8; Q15103; Q503B0; Q6PJA5; Q7Z7N2; Q86YK8;
AC   Q9BU99; Q9BZW1;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   15-JUN-2010, entry version 158.
DE   RecName: Full=Tissue-type plasminogen activator;
DE            Short=t-plasminogen activator;
DE            Short=t-PA;
DE            Short=tPA;
DE            EC=3.4.21.68;
DE   AltName: INN=Alteplase;
DE   AltName: INN=Reteplase;
DE   Contains:
DE     RecName: Full=Tissue-type plasminogen activator chain A;
DE   Contains:
DE     RecName: Full=Tissue-type plasminogen activator chain B;
DE   Flags: Precursor;
GN   Name=PLAT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   MEDLINE=83115262; PubMed=6337343; DOI=10.1038/301214a0;
RA   Pennica D., Holmes W.E., Kohr W.J., Harkins R.N., Vehar G.A.,
RA   Ward C.A., Bennett W.F., Yelverton E., Seeburg P.H., Heyneker H.L.,
RA   Goeddel D.V., Collen D.;
RT   "Cloning and expression of human tissue-type plasminogen activator
RT   cDNA in E. coli.";
RL   Nature 301:214-221(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=84298137; PubMed=6089198; DOI=10.1073/pnas.81.17.5355;
RA   Ny T., Elgh F., Lund B.;
RT   "The structure of the human tissue-type plasminogen activator gene:
RT   correlation of intron and exon structures to functional and structural
RT   domains.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:5355-5359(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=86196143; PubMed=3009482;
RA   Friezner Degen S.J., Rajput B., Reich E.;
RT   "The human tissue plasminogen activator gene.";
RL   J. Biol. Chem. 261:6972-6985(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=86284200; PubMed=3090401;
RA   Harris T.J., Patel T., Marston F.A., Little S., Emtage J.S.,
RA   Opdenakker G., Volckaert G., Rombauts W., Billiau A., Somer P.;
RT   "Cloning of cDNA coding for human tissue-type plasminogen activator
RT   and its expression in Escherichia coli.";
RL   Mol. Biol. Med. 3:279-292(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   MEDLINE=88054470; PubMed=2824147;
RA   Reddy V.B., Garramone A.J., Sasak H., Wei C.-M., Watkins P., Galli J.,
RA   Hsiung N.;
RT   "Expression of human uterine tissue-type plasminogen activator in
RT   mouse cells using BPV vectors.";
RL   DNA 6:461-472(1987).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal lung;
RX   MEDLINE=88262579; PubMed=3133640; DOI=10.1093/nar/16.12.5695;
RA   Sasaki H., Saito Y., Hayashi M., Otsuka K., Niwa M.;
RT   "Nucleotide sequence of the tissue-type plasminogen activator cDNA
RT   from human fetal lung cells.";
RL   Nucleic Acids Res. 16:5695-5695(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Umbilical vein;
RX   MEDLINE=90192129; PubMed=2107528; DOI=10.1093/nar/18.4.1086;
RA   Siebert P.D., Fong K.;
RT   "Variant tissue-type plasminogen activator (PLAT) cDNA obtained from
RT   human endothelial cells.";
RL   Nucleic Acids Res. 18:1086-1086(1990).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RA   Dou D.;
RT   "A brain-type plasminogen activator.";
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Liu Y., Xu L., Zeng Y., He X.;
RT   "cDNA of tissue plasminogen activator.";
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ASP-34; SER-136;
RP   THR-146 AND TRP-164.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-36.
RX   MEDLINE=85289338; PubMed=3161893;
RA   Fisher R., Waller E.K., Grossi G., Thompson D., Tizard R.,
RA   Schleuning W.-D.;
RT   "Isolation and characterization of the human tissue-type plasminogen
RT   activator structural gene including its 5' flanking region.";
RL   J. Biol. Chem. 260:11223-11230(1985).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 31-562.
RX   MEDLINE=91291340; PubMed=1368681;
RA   Itagaki Y., Yasuda H., Morinaga T., Mitsuda S., Higashio K.;
RT   "Purification and characterization of tissue plasminogen activator
RT   secreted by human embryonic lung diploid fibroblasts, IMR-90 cells.";
RL   Agric. Biol. Chem. 55:1225-1232(1991).
RN   [17]
RP   PROTEIN SEQUENCE OF 33-52 AND 311-330.
RC   TISSUE=Melanoma;
RX   MEDLINE=83209620; PubMed=6682760;
RX   DOI=10.1111/j.1432-1033.1983.tb07418.x;
RA   Wallen P., Pohl G., Bergsdorf N., Raanby M., Ny T., Joernvall H.;
RT   "Purification and characterization of a melanoma cell plasminogen
RT   activator.";
RL   Eur. J. Biochem. 132:681-686(1983).
RN   [18]
RP   PROTEIN SEQUENCE OF 36-562.
RC   TISSUE=Melanoma;
RX   MEDLINE=85000468; PubMed=6433976; DOI=10.1021/bi00311a020;
RA   Pohl G., Kaellstroem M., Bergsdorf N., Wallen P., Joernvall H.;
RT   "Tissue plasminogen activator: peptide analyses confirm an indirectly
RT   derived amino acid sequence, identify the active site serine residue,
RT   establish glycosylation sites, and localize variant differences.";
RL   Biochemistry 23:3701-3707(1984).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 251-358.
RX   MEDLINE=83169656; PubMed=6572897; DOI=10.1073/pnas.80.2.349;
RA   Edlund T., Ny T., Raanby M., Heden L.-O., Palm G., Holmgren E.,
RA   Josephson S.;
RT   "Isolation of cDNA sequences coding for a part of human tissue
RT   plasminogen activator.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:349-352(1983).
RN   [20]
RP   PARTIAL PROTEIN SEQUENCE, AND SIGNAL SEQUENCE CLEAVAGE SITE.
RA   Jalah R., Pavlakis G.N., Felber B.J.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [21]
RP   STRUCTURE OF CARBOHYDRATES.
RX   MEDLINE=90092112; PubMed=2513186;
RX   DOI=10.1111/j.1432-1033.1989.tb15206.x;
RA   Pfeiffer G., Schmidt M., Strube K.-H., Geyer R.;
RT   "Carbohydrate structure of recombinant human uterine tissue
RT   plasminogen activator expressed in mouse epithelial cells.";
RL   Eur. J. Biochem. 186:273-286(1989).
RN   [22]
RP   GLYCOSYLATION AT THR-96.
RX   MEDLINE=91159408; PubMed=1900431; DOI=10.1021/bi00223a004;
RA   Harris R.J., Leonard C.K., Guzzetta A.W., Spellman M.W.;
RT   "Tissue plasminogen activator has an O-linked fucose attached to
RT   threonine-61 in the epidermal growth factor domain.";
RL   Biochemistry 30:2311-2314(1991).
RN   [23]
RP   DISULFIDE BONDS IN KRINGLE 2.
RX   MEDLINE=91244765; PubMed=1645336;
RA   Vlahos C.J., Wilhelm O.G., Hassell T., Jaskunas S.R., Bang N.U.;
RT   "Disulfide pairing of the recombinant kringle-2 domain of tissue
RT   plasminogen activator produced in Escherichia coli.";
RL   J. Biol. Chem. 266:10070-10072(1991).
RN   [24]
RP   INTERACTION WITH LRP1B.
RX   MEDLINE=21369943; PubMed=11384978; DOI=10.1074/jbc.M102727200;
RA   Liu C.-X., Li Y., Obermoeller-McCormick L.M., Schwartz A.L., Bu G.;
RT   "The putative tumor suppressor LRP1B, a novel member of the low
RT   density lipoprotein (LDL) receptor family, exhibits both overlapping
RT   and distinct properties with the LDL receptor-related protein.";
RL   J. Biol. Chem. 276:28889-28896(2001).
RN   [25]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [26]
RP   STRUCTURE BY NMR OF KRINGLE 2.
RX   MEDLINE=90122799; PubMed=2558718; DOI=10.1021/bi00450a016;
RA   Byeon I.-J.L., Kelley R.F., Llinas M.;
RT   "1H NMR structural characterization of a recombinant kringle 2 domain
RT   from human tissue-type plasminogen activator.";
RL   Biochemistry 28:9350-9360(1989).
RN   [27]
RP   STRUCTURE BY NMR OF KRINGLE 2.
RX   MEDLINE=91200042; PubMed=1901789;
RX   DOI=10.1111/j.1432-1033.1991.tb15894.x;
RA   Byeon I.-J.L., Kelley R.F., Llinas M.;
RT   "Kringle-2 domain of the tissue-type plasminogen activator. 1H-NMR
RT   assignments and secondary structure.";
RL   Eur. J. Biochem. 197:155-165(1991).
RN   [28]
RP   STRUCTURE BY NMR OF KRINGLE 2.
RX   MEDLINE=92106329; PubMed=1762144; DOI=10.1016/0022-2836(91)90592-T;
RA   Byeon I.-J.L., Llinas M.;
RT   "Solution structure of the tissue-type plasminogen activator kringle 2
RT   domain complexed to 6-aminohexanoic acid an antifibrinolytic drug.";
RL   J. Mol. Biol. 222:1035-1051(1991).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF KRINGLE 2.
RX   MEDLINE=92118803; PubMed=1310033; DOI=10.1021/bi00116a037;
RA   de Vos A., Ultsch M.H., Kelley R.F., Padmanabhan K., Tulinskly A.,
RA   Westbrook M.L., Kossiakof A.A.;
RT   "Crystal structure of the kringle 2 domain of tissue plasminogen
RT   activator at 2.4-A resolution.";
RL   Biochemistry 31:270-279(1992).
RN   [30]
RP   STRUCTURE BY NMR OF 38-85.
RX   MEDLINE=92292163; PubMed=1602484; DOI=10.1016/0022-2836(92)90403-7;
RA   Downing A.K., Driscoll P.C., Harvey T.S., Dudgeon T.J., Smith B.O.,
RA   Baron M., Campbell I.D.;
RT   "Solution structure of the fibrin binding finger domain of tissue-type
RT   plasminogen activator determined by 1H nuclear magnetic resonance.";
RL   J. Mol. Biol. 225:821-833(1992).
RN   [31]
RP   STRUCTURE BY NMR OF 36-126.
RX   MEDLINE=96027104; PubMed=7582899; DOI=10.1016/S0969-2126(01)00217-9;
RA   Smith B.O., Downing A.K., Driscoll P.C., Dudgeon T.J., Campbell I.D.;
RT   "The solution structure and backbone dynamics of the fibronectin type
RT   I and epidermal growth factor-like pair of modules of tissue-type
RT   plasminogen activator.";
RL   Structure 3:823-833(1995).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF CATALYTIC DOMAIN.
RX   MEDLINE=96200985; PubMed=8613982; DOI=10.1006/jmbi.1996.0238;
RA   Lamba D., Bauer M., Huber R., Fischer S., Rudolph R., Kohnert U.,
RA   Bode W.;
RT   "The 2.3 A crystal structure of the catalytic domain of recombinant
RT   two-chain human tissue-type plasminogen activator.";
RL   J. Mol. Biol. 258:117-135(1996).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF CATALYTIC DOMAIN.
RX   MEDLINE=97449126; PubMed=9305622; DOI=10.1093/emboj/16.16.4797;
RA   Renatus M., Engh R.A., Stubbs M.T., Huber R., Fischer S., Kohnert U.,
RA   Bode W.;
RT   "Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray
RT   crystal structure of single-chain human tPA.";
RL   EMBO J. 16:4797-4805(1997).
CC   -!- FUNCTION: Converts the abundant, but inactive, zymogen plasminogen
CC       to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By
CC       controlling plasmin-mediated proteolysis, it plays an important
CC       role in tissue remodeling and degradation, in cell migration and
CC       many other physiopathological events. Play a direct role in
CC       facilitating neuronal migration.
CC   -!- CATALYTIC ACTIVITY: Specific cleavage of Arg-|-Val bond in
CC       plasminogen to form plasmin.
CC   -!- SUBUNIT: Heterodimer of chain A and chain B held by a disulfide
CC       bond. Binds to fibrin with high affinity. This interaction leads
CC       to an increase in the catalytic efficiency of the enzyme between
CC       100-fold and 1000-fold, due to an increase in affinity for
CC       plasminogen. Similarly, binding to heparin increases the
CC       activation of plasminogen. Binds to annexin A2, cytokeratin-8,
CC       fibronectin and laminin. Binds to mannose receptor and the low-
CC       density lipoprotein receptor-related protein (LRP1); these
CC       proteins are involved in TPA clearance. Yet unidentified
CC       interactions on endothelial cells and vascular smooth muscle cells
CC       (VSMC) lead to a 100-fold stimulation of plasminogen activation.
CC       In addition, binding to VSMC reduces TPA inhibition by PAI-1 by
CC       30-fold. Binds LRP1B; binding is followed by internalization and
CC       degradation.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=P00750-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P00750-2; Sequence=VSP_005411, VSP_005412;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay;
CC       Name=3;
CC         IsoId=P00750-3; Sequence=VSP_015957;
CC         Note=No experimental confirmation available;
CC       Name=4; Synonyms=Neonatal;
CC         IsoId=P00750-4; Sequence=VSP_028029, VSP_028030;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Synthesized in numerous tissues (including
CC       tumors) and secreted into most extracellular body fluids, such as
CC       plasma, uterine fluid, saliva, gingival crevicular fluid, tears,
CC       seminal fluid, and milk.
CC   -!- DOMAIN: Both FN1 and one of the kringle domains are required for
CC       binding to fibrin.
CC   -!- DOMAIN: Both FN1 and EGF-like domains are important for binding to
CC       LRP1.
CC   -!- DOMAIN: The FN1 domain mediates binding to annexin A2.
CC   -!- DOMAIN: The second kringle domain is implicated in binding to
CC       cytokeratin-8 and to the endothelial cell surface binding site.
CC   -!- PTM: The single chain, almost fully active enzyme, can be further
CC       processed into a two-chain fully active form by a cleavage after
CC       Arg-310 catalyzed by plasmin, tissue kallikrein or factor Xa.
CC   -!- PTM: Differential cell-specific N-linked glycosylation gives rise
CC       to two glycoforms, type I (glycosylated at Asn-219) and type II
CC       (not glycosylated at Asn-219). The single chain type I glycoform
CC       is less readily converted into the two-chain form by plasmin, and
CC       the two-chain type I glycoform has a lower activity than the two-
CC       chain type II glycoform in the presence of fibrin.
CC   -!- PTM: N-glycosylation of Asn-152; the bound oligomannosidic glycan
CC       is involved in the interaction with the mannose receptor.
CC   -!- PTM: Characterization of O-linked glycan was studied in Bowes
CC       melanoma cell line.
CC   -!- DISEASE: Increased activity of TPA is the cause of
CC       hyperfibrinolysis [MIM:173370]. Hyperfibrinolysis leads to
CC       excessive bleeding. Defective release of TPA causes
CC       hypofibrinolysis, leading to thrombosis or embolism.
CC   -!- PHARMACEUTICAL: Available under the names Activase (Genentech) and
CC       Retavase (Centocor and Roche) [Retavase is a fragment of TPA that
CC       contains kringle 2 and the protease domain; it was also known as
CC       BM 06.022]. Used in Acute Myocardial Infarction (AMI), in Acute
CC       Ischemic Stroke (AIS) and Pulmonary Embolism (PE) to initiate
CC       fibrinolysis.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC   -!- SIMILARITY: Contains 1 EGF-like domain.
CC   -!- SIMILARITY: Contains 1 fibronectin type-I domain.
CC   -!- SIMILARITY: Contains 2 kringle domains.
CC   -!- SIMILARITY: Contains 1 peptidase S1 domain.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Tissue plasminogen activator
CC       entry;
CC       URL="http://en.wikipedia.org/wiki/Tissue_plasminogen_Activator";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/plat/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=PLAT";
CC   -!- WEB RESOURCE: Name=Activase; Note=Clinical information on
CC       Activase;
CC       URL="http://www.gene.com/gene/products/information/cardiovascular/activase/index.jsp";
CC   -!- WEB RESOURCE: Name=Retavase; Note=Clinical information on
CC       Retavase;
CC       URL="http://www.retavase.com/pdf/Retavase_PI.pdf";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L00153; AAB59510.1; -; Genomic_DNA.
DR   EMBL; L00141; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00142; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00143; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00144; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00145; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00146; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00147; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00148; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00149; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00150; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; L00151; AAB59510.1; JOINED; Genomic_DNA.
DR   EMBL; K03021; AAA98809.1; -; Genomic_DNA.
DR   EMBL; M15518; AAA60111.1; -; mRNA.
DR   EMBL; M18182; AAA36800.1; -; mRNA.
DR   EMBL; X07393; CAA30302.1; -; mRNA.
DR   EMBL; X13097; CAA31489.1; -; mRNA.
DR   EMBL; AF260825; AAK11956.1; -; mRNA.
DR   EMBL; AY221101; AAO34406.1; -; mRNA.
DR   EMBL; AK289387; BAF82076.1; -; mRNA.
DR   EMBL; AK290575; BAF83264.1; -; mRNA.
DR   EMBL; AK313342; BAG36145.1; -; mRNA.
DR   EMBL; BT007060; AAP35709.1; -; mRNA.
DR   EMBL; AY291060; AAP34246.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63235.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63233.1; -; Genomic_DNA.
DR   EMBL; BC002795; AAH02795.3; -; mRNA.
DR   EMBL; BC007231; AAH07231.1; -; mRNA.
DR   EMBL; BC013968; AAH13968.3; -; mRNA.
DR   EMBL; BC018636; AAH18636.3; -; mRNA.
DR   EMBL; BC095403; AAH95403.1; -; mRNA.
DR   EMBL; M11890; AAA61213.1; -; Genomic_DNA.
DR   EMBL; M11889; AAA61213.1; JOINED; Genomic_DNA.
DR   EMBL; D01096; BAA00881.1; -; mRNA.
DR   EMBL; V00570; CAA23833.1; -; mRNA.
DR   IPI; IPI00019590; -.
DR   IPI; IPI00479511; -.
DR   IPI; IPI00910450; -.
DR   IPI; IPI00953228; -.
DR   PIR; A94004; UKHUT.
DR   PIR; I38098; I38098.
DR   RefSeq; NP_000921.1; -.
DR   RefSeq; NP_127509.1; -.
DR   UniGene; Hs.491582; -.
DR   PDB; 1A5H; X-ray; 2.90 A; A/B=311-562, C/D=298-304.
DR   PDB; 1BDA; X-ray; 3.35 A; A/B=298-562.
DR   PDB; 1PK2; NMR; -; A=209-298.
DR   PDB; 1PML; X-ray; 2.38 A; A/B/C=213-298.
DR   PDB; 1RTF; X-ray; 2.30 A; B=311-562.
DR   PDB; 1TPG; NMR; -; A=36-126.
DR   PDB; 1TPK; X-ray; 2.40 A; A/B/C=211-298.
DR   PDB; 1TPM; NMR; -; A=36-85.
DR   PDB; 1TPN; NMR; -; A=36-85.
DR   PDBsum; 1A5H; -.
DR   PDBsum; 1BDA; -.
DR   PDBsum; 1PK2; -.
DR   PDBsum; 1PML; -.
DR   PDBsum; 1RTF; -.
DR   PDBsum; 1TPG; -.
DR   PDBsum; 1TPK; -.
DR   PDBsum; 1TPM; -.
DR   PDBsum; 1TPN; -.
DR   SMR; P00750; 126-210, 174-299, 212-334.
DR   STRING; P00750; -.
DR   MEROPS; S01.232; -.
DR   GlycoSuiteDB; P00750; -.
DR   PRIDE; P00750; -.
DR   Ensembl; ENST00000220809; ENSP00000220809; ENSG00000104368; Homo sapiens.
DR   GeneID; 5327; -.
DR   KEGG; hsa:5327; -.
DR   UCSC; uc003xos.2; human.
DR   UCSC; uc003xot.2; human.
DR   UCSC; uc010lxf.1; human.
DR   CTD; 5327; -.
DR   GeneCards; GC08M042151; -.
DR   H-InvDB; HIX0007476; -.
DR   HGNC; HGNC:9051; PLAT.
DR   HPA; CAB009335; -.
DR   HPA; HPA003412; -.
DR   MIM; 173370; gene+phenotype.
DR   PharmGKB; PA33381; -.
DR   eggNOG; prNOG16610; -.
DR   HOVERGEN; HBG008633; -.
DR   InParanoid; P00750; -.
DR   OMA; TCGLRQY; -.
DR   OrthoDB; EOG9TQPVK; -.
DR   PhylomeDB; P00750; -.
DR   BRENDA; 3.4.21.68; 247.
DR   Pathway_Interaction_DB; amb2_neutrophils_pathway; amb2 Integrin signaling.
DR   Reactome; REACT_16888; Signaling by PDGF.
DR   Reactome; REACT_604; Hemostasis.
DR   DrugBank; DB00009; Alteplase.
DR   DrugBank; DB00513; Aminocaproic Acid.
DR   DrugBank; DB00029; Anistreplase.
DR   DrugBank; DB01088; Iloprost.
DR   DrugBank; DB00015; Reteplase.
DR   DrugBank; DB00031; Tenecteplase.
DR   DrugBank; DB00302; Tranexamic Acid.
DR   DrugBank; DB00013; Urokinase.
DR   NextBio; 20622; -.
DR   PMAP-CutDB; P00750; -.
DR   ArrayExpress; P00750; -.
DR   Bgee; P00750; -.
DR   Genevestigator; P00750; -.
DR   GermOnline; ENSG00000104368; Homo sapiens.
DR   GO; 0009986; C:cell surface; IDA:UniProtKB.
DR   GO; 0005615; C:extracellular space; IEA:UniProtKB-SubCell.
DR   GO; 0005515; F:protein binding; IPI:UniProtKB.
DR   GO; 0004252; F:serine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; 0007596; P:blood coagulation; TAS:ProtInc.
DR   GO; 0045861; P:negative regulation of proteolysis; IDA:UniProtKB.
DR   GO; 0006464; P:protein modification process; TAS:ProtInc.
DR   GO; 0006508; P:proteolysis; TAS:ProtInc.
DR   InterPro; IPR016060; Complement_control_module.
DR   InterPro; IPR006209; EGF.
DR   InterPro; IPR006210; EGF-like.
DR   InterPro; IPR013032; EGF-like_reg_CS.
DR   InterPro; IPR000742; EGF_3.
DR   InterPro; IPR000083; Fibrnctn1.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR018059; Kringle_sub.
DR   InterPro; IPR018114; Peptidase_S1/S6_AS.
DR   InterPro; IPR001254; Peptidase_S1_S6.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR009003; Ser/Cys_Pept_Trypsin-like.
DR   Gene3D; G3DSA:2.10.70.10; Complement_control_module; 1.
DR   Gene3D; G3DSA:2.40.20.10; Kringle; 2.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF00039; fn1; 1.
DR   Pfam; PF00051; Kringle; 2.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   PRINTS; PR00018; KRINGLE.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00058; FN1; 1.
DR   SMART; SM00130; KR; 2.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF57440; Kringle-like; 2.
DR   SUPFAM; SSF50494; Pept_Ser_Cys; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS01253; FN1_1; 1.
DR   PROSITE; PS51091; FN1_2; 1.
DR   PROSITE; PS00021; KRINGLE_1; 2.
DR   PROSITE; PS50070; KRINGLE_2; 2.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Hydrolase; Kringle; Pharmaceutical;
KW   Plasminogen activation; Polymorphism; Protease; Repeat; Secreted;
KW   Serine protease; Signal; Zymogen.
FT   SIGNAL        1     22
FT   PROPEP       23     32
FT                                /FTId=PRO_0000028348.
FT   PROPEP       33     35       Removed by plasmin.
FT                                /FTId=PRO_0000028349.
FT   CHAIN        36    562       Tissue-type plasminogen activator.
FT                                /FTId=PRO_0000028350.
FT   CHAIN        36    310       Tissue-type plasminogen activator chain
FT                                A.
FT                                /FTId=PRO_0000028351.
FT   CHAIN       311    562       Tissue-type plasminogen activator chain
FT                                B.
FT                                /FTId=PRO_0000028352.
FT   DOMAIN       39     81       Fibronectin type-I.
FT   DOMAIN       82    120       EGF-like.
FT   DOMAIN      127    208       Kringle 1.
FT   DOMAIN      215    296       Kringle 2.
FT   DOMAIN      311    561       Peptidase S1.
FT   REGION       42     52       Important for binding to annexin A2.
FT   ACT_SITE    357    357       Charge relay system.
FT   ACT_SITE    406    406       Charge relay system.
FT   ACT_SITE    513    513       Charge relay system.
FT   SITE        102    102       Important for binding to LRP1.
FT   SITE        253    253       Not glycosylated.
FT   SITE        464    464       Important for single-chain activity.
FT   SITE        512    512       Important for single-chain activity.
FT   CARBOHYD     96     96       O-linked (Fuc).
FT                                /FTId=CAR_000029.
FT   CARBOHYD    152    152       N-linked (GlcNAc...).
FT   CARBOHYD    219    219       N-linked (GlcNAc...); partial.
FT                                /FTId=CAR_000030.
FT   CARBOHYD    483    483       N-linked (GlcNAc...).
FT                                /FTId=CAR_000031.
FT   DISULFID     41     71
FT   DISULFID     69     78
FT   DISULFID     86     97
FT   DISULFID     91    108
FT   DISULFID    110    119
FT   DISULFID    127    208       By similarity.
FT   DISULFID    148    190       By similarity.
FT   DISULFID    179    203       By similarity.
FT   DISULFID    215    296
FT   DISULFID    236    278
FT   DISULFID    267    291
FT   DISULFID    299    430       Interchain (between A and B chains).
FT   DISULFID    342    358       By similarity.
FT   DISULFID    350    419       By similarity.
FT   DISULFID    444    519       By similarity.
FT   DISULFID    476    492       By similarity.
FT   DISULFID    509    537       By similarity.
FT   VAR_SEQ       1     40       MDAMKRGLCCVLLLCGAVFVSPSQEIHARFRRGARSYQVI
FT                                -> MAS (in isoform 4).
FT                                /FTId=VSP_028029.
FT   VAR_SEQ      39     85       VICRDEKTQMIYQQHQSWLRPVLRSNRVEYCWCNSGRAQCH
FT                                SVPVKS -> G (in isoform 3).
FT                                /FTId=VSP_015957.
FT   VAR_SEQ      79    208       Missing (in isoform 4).
FT                                /FTId=VSP_028030.
FT   VAR_SEQ     269    291       NPDGDAKPWCHVLKNRRLTWEYC -> TGRSVSSPATASMR
FT                                PCPLSIRSG (in isoform 2).
FT                                /FTId=VSP_005411.
FT   VAR_SEQ     292    562       Missing (in isoform 2).
FT                                /FTId=VSP_005412.
FT   VARIANT      34     34       A -> D (in dbSNP:rs8178733).
FT                                /FTId=VAR_020181.
FT   VARIANT     136    136       R -> S (in dbSNP:rs8178747).
FT                                /FTId=VAR_038732.
FT   VARIANT     146    146       A -> T (in dbSNP:rs8178748).
FT                                /FTId=VAR_038733.
FT   VARIANT     164    164       R -> W (in dbSNP:rs2020921).
FT                                /FTId=VAR_011783.
FT   CONFLICT     93     93       N -> T (in Ref. 2; AAB59510).
FT   CONFLICT    159    160       KP -> NA (in Ref. 7; CAA31489).
FT   CONFLICT    247    247       K -> N (in Ref. 9; AAO34406).
FT   CONFLICT    283    283       N -> S (in Ref. 14; AAH95403).
FT   CONFLICT    333    334       RR -> EE (in Ref. 8; AAK11956).
FT   CONFLICT    389    389       V -> C (in Ref. 8; AAK11956).
FT   STRAND       44     46
FT   STRAND       55     59
FT   STRAND       61     64
FT   STRAND       66     70
FT   STRAND       72     74
FT   STRAND       83     85
FT   STRAND       96    104
FT   STRAND      106    109
FT   STRAND      115    118
FT   HELIX       242    244
FT   STRAND      248    250
FT   HELIX       256    259
FT   STRAND      262    264
FT   STRAND      277    282
FT   STRAND      285    291
FT   STRAND      312    316
FT   HELIX       319    321
FT   STRAND      325    331
FT   STRAND      338    346
FT   STRAND      348    354
FT   HELIX       356    359
FT   HELIX       365    367
FT   STRAND      368    373
FT   STRAND      375    379
FT   STRAND      385    394
FT   TURN        400    402
FT   STRAND      408    412
FT   STRAND      415    417
FT   STRAND      443    449
FT   STRAND      464    470
FT   HELIX       473    475
FT   TURN        478    483
FT   STRAND      490    494
FT   STRAND      516    521
FT   STRAND      524    533
FT   STRAND      535    538
FT   STRAND      544    548
FT   HELIX       549    552
FT   HELIX       553    559
SQ   SEQUENCE   562 AA;  62917 MW;  B7EC9B1A5E3FDC4D CRC64;
     MDAMKRGLCC VLLLCGAVFV SPSQEIHARF RRGARSYQVI CRDEKTQMIY QQHQSWLRPV
     LRSNRVEYCW CNSGRAQCHS VPVKSCSEPR CFNGGTCQQA LYFSDFVCQC PEGFAGKCCE
     IDTRATCYED QGISYRGTWS TAESGAECTN WNSSALAQKP YSGRRPDAIR LGLGNHNYCR
     NPDRDSKPWC YVFKAGKYSS EFCSTPACSE GNSDCYFGNG SAYRGTHSLT ESGASCLPWN
     SMILIGKVYT AQNPSAQALG LGKHNYCRNP DGDAKPWCHV LKNRRLTWEY CDVPSCSTCG
     LRQYSQPQFR IKGGLFADIA SHPWQAAIFA KHRRSPGERF LCGGILISSC WILSAAHCFQ
     ERFPPHHLTV ILGRTYRVVP GEEEQKFEVE KYIVHKEFDD DTYDNDIALL QLKSDSSRCA
     QESSVVRTVC LPPADLQLPD WTECELSGYG KHEALSPFYS ERLKEAHVRL YPSSRCTSQH
     LLNRTVTDNM LCAGDTRSGG PQANLHDACQ GDSGGPLVCL NDGRMTLVGI ISWGLGCGQK
     DVPGVYTKVT NYLDWIRDNM RP
//
ID   CBBQ_CHRVI              Reviewed;          74 AA.
AC   P56540;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 1.
DT   19-JAN-2010, entry version 30.
DE   RecName: Full=Protein cbbQ;
DE   Flags: Fragment;
GN   Name=cbbQ;
OS   Chromatium vinosum (Allochromatium vinosum).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Chromatiales;
OC   Chromatiaceae; Allochromatium.
OX   NCBI_TaxID=1049;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=89213919; PubMed=2708310;
RA   Viale A.M., Kobayashi H., Akazawa T.;
RT   "Expressed genes for plant-type ribulose 1,5-bisphosphate
RT   carboxylase/oxygenase in the photosynthetic bacterium Chromatium
RT   vinosum, which possesses two complete sets of the genes.";
RL   J. Bacteriol. 171:2391-2400(1989).
RN   [2]
RP   IDENTIFICATION.
RX   MEDLINE=95189107; PubMed=7883189; DOI=10.1016/0378-1119(94)00808-6;
RA   Yokoyama K., Hayashi N.R., Arai H., Chung S.Y., Igarashi Y.,
RA   Kodama T.;
RT   "Genes encoding RubisCO in Pseudomonas hydrogenothermophila are
RT   followed by a novel cbbQ gene similar to nirQ of the denitrification
RT   gene cluster from Pseudomonas species.";
RL   Gene 153:75-79(1995).
CC   -!- FUNCTION: May affect the post-translational activation and/or
CC       assembly of the oligomeric structure of RuBisCO.
CC   -!- SIMILARITY: Belongs to the cbbQ/nirQ/norQ/gpvN family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M26396; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   SMR; P56540; 10-72.
DR   GO; 0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; 0016887; F:ATPase activity; IEA:InterPro.
DR   InterPro; IPR011704; ATPase_AAA-5.
DR   Pfam; PF07728; AAA_5; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Nucleotide-binding.
FT   CHAIN         1    >74       Protein cbbQ.
FT                                /FTId=PRO_0000219562.
FT   NP_BIND      41     48       ATP (Potential).
FT   NON_TER      74     74
SQ   SEQUENCE   74 AA;  8377 MW;  B7AB23BF4DEA291C CRC64;
     MSDIDRNQFL IDHEPYYRPV SNEVALYEAA YAARMPVMLK GPTGCGKTRF VEYMAWKLGK
     PLITVACNED MTAS
//
ID   CBBQ_PSEHY              Reviewed;         267 AA.
AC   Q51858;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   13-JUL-2010, entry version 35.
DE   RecName: Full=Protein cbbQ;
GN   Name=cbbQ;
OS   Pseudomonas hydrogenothermophila.
OC   Bacteria; Proteobacteria; Betaproteobacteria; Hydrogenophilales;
OC   Hydrogenophilaceae; Hydrogenophilus.
OX   NCBI_TaxID=297;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=TH-1;
RX   MEDLINE=95189107; PubMed=7883189; DOI=10.1016/0378-1119(94)00808-6;
RA   Yokoyama K., Hayashi N.R., Arai H., Chung S.Y., Igarashi Y.,
RA   Kodama T.;
RT   "Genes encoding RubisCO in Pseudomonas hydrogenothermophila are
RT   followed by a novel cbbQ gene similar to nirQ of the denitrification
RT   gene cluster from Pseudomonas species.";
RL   Gene 153:75-79(1995).
CC   -!- FUNCTION: May affect the post-translational activation and/or
CC       assembly of the oligomeric structure of RuBisCO.
CC   -!- SIMILARITY: Belongs to the cbbQ/nirQ/norQ/gpvN family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D30764; BAA06439.1; -; Genomic_DNA.
DR   SMR; Q51858; 21-191.
DR   GO; 0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; 0016887; F:ATPase activity; IEA:InterPro.
DR   InterPro; IPR011704; ATPase_AAA-5.
DR   InterPro; IPR013615; CbbQ_C.
DR   Pfam; PF07728; AAA_5; 1.
DR   Pfam; PF08406; CbbQ_C; 1.
PE   3: Inferred from homology;
KW   ATP-binding; Nucleotide-binding.
FT   CHAIN         1    267       Protein cbbQ.
FT                                /FTId=PRO_0000219563.
FT   NP_BIND      39     46       ATP (Potential).
FT   NP_BIND      99    106       ATP (Potential).
SQ   SEQUENCE   267 AA;  29613 MW;  EA99FE2DB05B0118 CRC64;
     MDLRNQYLVR SEPYYHAVGD EIERFEAAYA NRIPMMLKGP TGCGKSRFVE YMAWKLGKPL
     ITVACNEDMT AADLVGRFLL DKEGTRWQDG PLTTAARIGA ICYLDEVVEA RQDTTVVIHP
     LTDHRRILPL DKKGEVVEAH PDFQIVISYN PGYQSAMKDL KTSTKQRFAA MDFDYPAPEV
     ESEIVAHESG VDAATAKKLV EVAIRSRHLK GHGLDEGIST RLLVYAGSLI TKGIAPLIAC
     EMALICPITD DPDLRYALRA AAQTLFA
//
ID   NIRQ_PSEAE              Reviewed;         260 AA.
AC   Q51481;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   13-JUL-2010, entry version 65.
DE   RecName: Full=Denitrification regulatory protein nirQ;
GN   Name=nirQ; OrderedLocusNames=PA0520;
OS   Pseudomonas aeruginosa.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=287;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=PAO1161;
RX   MEDLINE=94362287; PubMed=7765251;
RA   Arai H., Igarashi Y., Kodama T.;
RT   "Structure and ANR-dependent transcription of the nir genes for
RT   denitrification from Pseudomonas aeruginosa.";
RL   Biosci. Biotechnol. Biochem. 58:1286-1291(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228;
RX   MEDLINE=20437337; PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T.,
RA   Reizer J., Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an
RT   opportunistic pathogen.";
RL   Nature 406:959-964(2000).
CC   -!- FUNCTION: Activator of nitrite and nitric oxide reductases.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (Potential).
CC   -!- INDUCTION: Under denitrifying conditions.
CC   -!- SIMILARITY: Belongs to the cbbQ/nirQ/norQ/gpvN family.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D37883; BAA07123.1; -; Genomic_DNA.
DR   EMBL; AE004091; AAG03909.1; -; Genomic_DNA.
DR   PIR; JC2288; JC2288.
DR   RefSeq; NP_249211.1; -.
DR   SMR; Q51481; 14-183.
DR   GeneID; 882214; -.
DR   GenomeReviews; AE004091_GR; PA0520.
DR   KEGG; pae:PA0520; -.
DR   NMPDR; fig|208964.1.peg.521; -.
DR   PseudoCAP; PA0520; -.
DR   HOGENOM; HBG295312; -.
DR   OMA; HEARILV; -.
DR   ProtClustDB; CLSK865916; -.
DR   BioCyc; PAER208964:PA0520-MONOMER; -.
DR   GO; 0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; 0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; 0016887; F:ATPase activity; IEA:InterPro.
DR   GO; 0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; 0045449; P:regulation of transcription; IEA:UniProtKB-KW.
DR   GO; 0006350; P:transcription; IEA:UniProtKB-KW.
DR   InterPro; IPR011704; ATPase_AAA-5.
DR   InterPro; IPR013615; CbbQ_C.
DR   Pfam; PF07728; AAA_5; 1.
DR   Pfam; PF08406; CbbQ_C; 1.
PE   2: Evidence at transcript level;
KW   Activator; ATP-binding; Complete proteome; Cytoplasm; DNA-binding;
KW   Nucleotide-binding; Transcription; Transcription regulation.
FT   CHAIN         1    260       Denitrification regulatory protein nirQ.
FT                                /FTId=PRO_0000219569.
FT   NP_BIND      32     39       ATP (Potential).
FT   NP_BIND      92     99       ATP (Potential).
FT   DNA_BIND    234    253       H-T-H motif (Potential).
SQ   SEQUENCE   260 AA;  28904 MW;  3FD36F19BEBA38B5 CRC64;
     MRDATPFYEA TGHEIEVFER AWRHGLPVLL KGPTGCGKTR FVQYMARRLE LPLYSVACHD
     DLGAADLLGR HLIGADGTWW QDGPLTRAVR EGGICYLDEV VEARQDTTVA IHPLADDRRE
     LYLERTGETL QAPPSFMLVV SYNPGYQNLL KGLKPSTRQR FVALRFDYPA AQQEARILVG
     ESGCAETLAQ RLVQLGQALR RLEQHDLEEV ASTRLLIFAA RLIGDGMDPR EACRVALAEP
     LSDDPATVAA LMDIVDLHVA
//
